Oranda, Ramel L.
HRN: 22-41-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
AMPICILLIN 500MG (VIAL)
05/04/2023
05/10/2023
IV
305mg
Q6h
PCAP Severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes